Cardinal Health, Inc. (CAH) Given Consensus Rating of “Hold” by Brokerages
Shares of Cardinal Health, Inc. (NYSE:CAH) have received a consensus rating of “Hold” from the twenty research firms that are currently covering the company, MarketBeat.com reports. Two equities research analysts have rated the stock with a sell rating, fourteen have given a hold rating and four have assigned a buy rating to the company. The average 1-year target price among brokerages that have issued a report on the stock in the last year is $80.66.
Several brokerages have weighed in on CAH. UBS AG reaffirmed a “neutral” rating and issued a $76.00 price objective (down from $79.00) on shares of Cardinal Health in a report on Wednesday, August 9th. Zacks Investment Research cut Cardinal Health from a “hold” rating to a “sell” rating in a report on Monday, August 7th. BidaskClub cut Cardinal Health from a “hold” rating to a “sell” rating in a report on Friday, August 4th. Cowen and Company reaffirmed a “market perform” rating and issued a $77.00 price objective (down from $82.00) on shares of Cardinal Health in a report on Thursday, August 3rd. Finally, Credit Suisse Group AG dropped their price objective on Cardinal Health from $87.00 to $81.00 and set an “outperform” rating for the company in a report on Thursday, August 3rd.
Shares of Cardinal Health (NYSE:CAH) traded down 0.49% during mid-day trading on Tuesday, reaching $66.43. The company’s stock had a trading volume of 2,004,008 shares. Cardinal Health has a 52-week low of $62.70 and a 52-week high of $84.88. The firm has a 50 day moving average price of $74.93 and a 200 day moving average price of $76.79. The firm has a market cap of $20.99 billion, a price-to-earnings ratio of 16.48 and a beta of 0.80.
Cardinal Health (NYSE:CAH) last announced its quarterly earnings data on Wednesday, August 2nd. The company reported $1.31 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.24 by $0.07. The firm had revenue of $32.97 billion during the quarter, compared to analysts’ expectations of $32.73 billion. Cardinal Health had a return on equity of 26.20% and a net margin of 0.99%. The company’s quarterly revenue was up 5.0% compared to the same quarter last year. During the same period in the previous year, the firm earned $1.14 EPS. On average, equities analysts predict that Cardinal Health will post $4.97 EPS for the current fiscal year.
The firm also recently declared a quarterly dividend, which will be paid on Sunday, October 15th. Stockholders of record on Monday, October 2nd will be paid a $0.4624 dividend. The ex-dividend date of this dividend is Friday, September 29th. This represents a $1.85 annualized dividend and a dividend yield of 2.78%. Cardinal Health’s payout ratio is 45.79%.
Several institutional investors have recently modified their holdings of the stock. Hexavest Inc. raised its stake in shares of Cardinal Health by 5.7% in the first quarter. Hexavest Inc. now owns 1,005,613 shares of the company’s stock worth $82,008,000 after buying an additional 54,163 shares in the last quarter. State of Alaska Department of Revenue raised its stake in shares of Cardinal Health by 63.5% in the first quarter. State of Alaska Department of Revenue now owns 8,155 shares of the company’s stock worth $664,000 after buying an additional 3,167 shares in the last quarter. Rothschild Investment Corp IL raised its stake in shares of Cardinal Health by 12.1% in the first quarter. Rothschild Investment Corp IL now owns 6,031 shares of the company’s stock worth $492,000 after buying an additional 652 shares in the last quarter. Coastline Trust Co raised its stake in shares of Cardinal Health by 12.2% in the first quarter. Coastline Trust Co now owns 4,310 shares of the company’s stock worth $351,000 after buying an additional 470 shares in the last quarter. Finally, DnB Asset Management AS raised its stake in shares of Cardinal Health by 19.7% in the first quarter. DnB Asset Management AS now owns 37,083 shares of the company’s stock worth $3,024,000 after buying an additional 6,100 shares in the last quarter. Institutional investors own 86.41% of the company’s stock.
About Cardinal Health
Cardinal Health, Inc is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also operates nuclear pharmacies and cyclotron facilities; provides pharmacy management services to hospitals, as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers, and provides services to healthcare companies.
Receive News & Ratings for Cardinal Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health Inc. and related companies with MarketBeat.com's FREE daily email newsletter.